|Description||Medical Device Company|
|Series D, 8/2009 |
|Grant, 7/2011 ||$1.4M|
|Series E, 8/2013 |
Sovereign Wealth Funds
Government Investment Funds
ConforMIS has developed the only line of personalized, partial knee resurfacing implants to treat knee osteoarthritis, one of the most common conditions facing our aging population.
ConforMIS is a privately held medical device company based in Massachusetts. It was founded in 2004 to provide dramatic advancements in patient care by utilizing imaging technology to create personalized, patient-specific implants and instrumentation.
ConforMIS transforms traditional CT and MRI data into patient-specific implants and instrumentation employing two related â€˜image-to-implantâ€™ technology platforms. Both platforms are supported by proprietary, intellectual property consisting of more than 250 patents and pending patent applications that span imaging software, image processing, implant design, surgical techniques and orthopedic instrumentation. The technology and patent portfolio is applicable to all major joint systems.
To date, ConforMIS has developed a comprehensive line of minimally traumatic implant solutions to address all stages of knee osteoarthritis, the most common reason for knee replacement surgery. Each of these devices has been cleared for marketing by the US Food and Drug Administration. Certain ConforMIS implants have also received CE Marking for the European region.
|iDuoâ„¢ Bicompartmental Knee Resurfacing Device|
|iFormaâ„¢ Knee Interpositional Device|
|iTotalâ„¢ Tricompartmental Knee Resurfacing Device|
|iUniâ„¢ Unicompartmental Knee Resurfacing Device|